Connective tissue disease

Connective tissue disease
Other names	Connective tissue disorder, collagen vascular diseases
Different types of connective tissue
Specialty	Rheumatology

Connective tissue diseases (also termed connective tissue disorders, or collagen vascular diseases), are medical conditions that affect connective tissue. ^[1]

Connective tissues protect, support, and provide structure for the body's other tissues and structures. ^[2] They hold the body's structures together. Connective tissues consist of two distinct proteins: elastin and collagen. Tendons, ligaments, skin, cartilage, bone, and blood vessels are all made of collagen. Skin and ligaments also contain elastin. These proteins and the surrounding tissues may suffer damage when the connective tissues become inflamed. ^[3]

The two main categories of connective tissue diseases are (1) a set of relatively rare genetic disorders affecting the primary structure of connective tissue, and (2) a variety of acquired diseases where the connective tissues are the site of multiple, more or less distinct immunological and inflammatory reactions.

Diseases in which inflammation or weakness of collagen tends to occur are also referred to as collagen diseases. Collagen vascular diseases can be (but are not necessarily) associated with collagen and blood vessel abnormalities that are autoimmune in nature.

Some connective tissue diseases have strong or weak genetic inheritance risks. Others may be due to environmental factors, or a combination of genetic and environmental influences.

Classification

Connective tissue disease is an umbrella term for many different types of diseases. ^[4] Connective tissue diseases can be classified into two groups:

1. a group of relatively rare genetic disorders affecting the primary structure of connective tissue;
2. a number of acquired conditions where the connective tissues are the site of multiple, more or less distinct immune and inflammatory reactions. ^[1]

Heritable connective tissue disorders

Hereditary connective tissue disorders are a diverse set of broad, single-gene disorders that impact one or more of the main components of connective tissues, such as ground substance (glycosaminoglycans), collagen, or elastin. Many result in anomalies of the skeleton and joints, which can substantially impair normal growth and development. In contrast to acquired connective tissue diseases, these conditions are uncommon. ^[1]

• Marfan syndrome - inherited as an autosomal dominant characteristic, due to mutations in the FBN1 gene that encodes fibrillin 1. ^[5]
• Homocystinuria - condition of methionine metabolism brought on by a cystathionine β-synthase deficit that causes a build-up of homocysteine and its metabolites in the urine and blood. ^[6]
• Ehlers–Danlos syndrome - diverse collection of disorders distinguished by the fragility of soft connective tissues and widespread symptoms affecting the skin, ligaments, joints, blood vessels, and internal organs. ^[7]
• Osteogenesis imperfecta - hereditary condition marked by reduced bone mass, weakened bones, increased brittleness, and short stature. ^[8]
• Alkaptonuria - inborn error of metabolism caused by mutations in the HGO gene and homogentisate 1,2-dioxygenase deficiency. ^{[9] [10]}
• Pseudoxanthoma elasticum - rare multisystem disease marked by gradual calcification and fragmentation of elastic fibres. ^[11]
• Mucopolysaccharidosis - a class of hereditary illnesses distinguished by the excretion of mucopolysaccharide in the urine. ^[12]
• Fibrodysplasia ossificans progressiva - rare and debilitating hereditary disorder characterized by progressive heterotopic ossification and congenital skeletal malformations. ^[13]
• Familial osteochondritis dissecans - separation of the subchondral bone and cartilage from the surrounding tissue. ^[14]
• Stickler syndrome - autosomal dominant disorder distinguished by skeletal, ocular, and orofacial abnormalities. ^[15]
• Alport syndrome - hereditary kidney disease is distinguished by structural abnormalities and malfunction in the glomerular basement membrane, as well as basement membranes in other organs such as the eye and ear. ^[16]
• Congenital contractural arachnodactyly - autosomal dominant disorder defined by arachnodactyly, multiple flexion contractures, abnormal pinnae, severe kyphoscoliosis, and muscular hypoplasia. ^[17]
• Epidermolysis bullosa - hereditary, diverse grouping of rare genetic dermatoses that are marked by blisters and mucocutaneous fragility. ^[18]
• Loeys–Dietz syndrome - autosomal dominant condition linked to a wide range of systemic manifestations, such as skeletal, cutaneous, vascular, and craniofacial abnormalities. ^[19]
• Hypermobility spectrum disorder - a variety of connective tissue diseases that are marked by ongoing pain and joint hypermobility. ^[20]

Autoimmune connective tissue disorders

Acquired connective tissue diseases share certain clinical features, such as joint inflammation, inflammation of serous membranes, and vasculitis, as well as a high frequency of involvement of various internal organs that are particularly rich in connective tissue. ^[1]

• Rheumatoid arthritis - autoimmune disease with an unclear cause that manifests as symmetric, erosive synovitis and, occasionally, extraarticular involvement. ^[21]
• Systemic lupus erythematosus - chronic, complex autoimmune inflammatory disorder that can affect every organ in the body. ^[22]
• Scleroderma and systemic scleroderma - diverse collection of autoimmune fibrosing conditions. ^[23]
• Dermatomyositis and polymyositis - autoimmune myopathies that are clinically characterized by extramuscular symptoms, muscle inflammation, proximal muscle weakening, and oftentimes the detection of autoantibodies. ^[24]
• Antisynthetase syndrome ^[25] - multisystematic autoimmune disease associated with inflammatory myositis and interstitial lung disease.
• Vasculitis - disease that results in blood vessel inflammation. ^[26]
• Sjögren syndrome - a systemic autoimmune illness that mostly affects the exocrine glands and causes mucosal surfaces, especially those in the mouth and eyes, to become extremely dry. ^[27]
• Rheumatic fever - multisystem inflammatory illness that develops after group A streptococcal pharyngitis. ^[28]
• Amyloidosis - uncommon condition caused by protein mutations or changes in the body that result in twisted clusters of malformed proteins accumulating on organs and tissues. ^[29]
• Osteoarthritis - common articular cartilage degenerative disease linked to hypertrophic bone abnormalities. ^[30]
• Thrombotic thrombocytopenic purpura - uncommon and potentially fatal thrombotic microangiopathy characterized by severe thrombocytopenia, organ ischemia connected to diffuse microvascular platelet rich-thrombi, and microangiopathic hemolytic anemia. ^[31]
• Relapsing polychondritis - uncommon multisystem autoimmune disease with an unclear etiology that is marked by progressive cartilaginous tissue loss and recurring episodes of inflammation. ^[32]
• Mixed connective tissue disease - systemic autoimmune disease that shares characteristics with two or more other systemic autoimmune diseases, such as rheumatoid arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus, and systemic sclerosis. ^[33] It is an example of overlap syndrome.
• Undifferentiated connective tissue disease - unclassifiable systemic autoimmune disorders that do not meet any of the current classification requirements for connective tissue diseases, yet have clinical and serological signs similar to connective tissue diseases. ^[34]
• Psoriatic arthritis - inflammatory musculoskeletal condition linked to psoriasis. ^[35]
• Cryoglobulinemia - condition sometimes associated with systemic lupus erythematosus or rheumatoid arthritis in which there are abnormal proteins in the blood. ^[25]
• IgG4-related disease ^[25] - chronic inflammatory condition in which there is deposition of connective tissue (fibrosis) in different organs. Potentially life-threatening.
• Periaortitis - a group of rare vascular inflammatory diseases in which fibrous inflammatory tissue develops around the aorta or other structures such as the ureters. ^[25] Sometimes associated with IgG4-related disease. ^[36]

References

1. Benedek, Thomas G.; Rodnan, Gerald P. (1998-07-24). "Description, Types, & Symptoms". Encyclopedia Britannica. Retrieved 2024-07-15.
2. Wedge, RA; Cartaxo, T; Spicer, CM, eds. (8 July 2022). "Overview of Hereditary Disorders of Connective Tissue". Selected Heritable Disorders of Connective Tissue and Disability. National Academies Press (US).
3. "Connective Tissue Disorders". Cedars-Sinai. 2020-06-08. Retrieved 2024-07-16.
4. Marwa, K; Anjum, F (2023). Undifferentiated Connective Tissue Disease. StatPearls. PMID   34283427.
5. Pepe, Guglielmina; Giusti, Betti; Sticchi, Elena; Abbate, Rosanna; Gensini, Gian; Nistri, Stefano (2016). "Marfan syndrome: current perspectives". The Application of Clinical Genetics. 9: 55–65. doi: 10.2147/TACG.S96233 . ISSN   1178-704X. PMC   4869846 . PMID   27274304.
6. Kumar, Tarun; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar (2016). "Homocystinuria: Therapeutic approach". Clinica Chimica Acta. 458: 55–62. doi:10.1016/j.cca.2016.04.002. ISSN   0009-8981. PMID   27059523.
7. De Paepe, A; Malfait, F (2012). "The Ehlers–Danlos syndrome, a disorder with many faces". Clinical Genetics. 82 (1): 1–11. doi:10.1111/j.1399-0004.2012.01858.x. ISSN   0009-9163. PMID   22353005.
8. Marini, Joan C.; Cabral, Wayne A. (2018). "Osteogenesis Imperfecta". Genetics of Bone Biology and Skeletal Disease. Elsevier. pp. 397–420. doi:10.1016/b978-0-12-804182-6.00023-x. ISBN   978-0-12-804182-6.
9. Bernardini, Giulia; Braconi, Daniela; Zatkova, Andrea; Sireau, Nick; Kujawa, Mariusz J.; Introne, Wendy J.; Spiga, Ottavia; Geminiani, Michela; Gallagher, James A.; Ranganath, Lakshminarayan R.; Santucci, Annalisa (2024-03-07). "Alkaptonuria". Nature Reviews Disease Primers. 10 (1): 16. doi:10.1038/s41572-024-00498-x. ISSN   2056-676X. PMID   38453957.
10. Phornphutkul, Chanika; Introne, Wendy J.; Perry, Monique B.; Bernardini, Isa; Murphey, Mark D.; Fitzpatrick, Diana L.; Anderson, Paul D.; Huizing, Marjan; Anikster, Yair; Gerber, Lynn H.; Gahl, William A. (2002-12-26). "Natural History of Alkaptonuria". New England Journal of Medicine. 347 (26): 2111–2121. doi:10.1056/NEJMoa021736. ISSN   0028-4793. PMID   12501223.
11. Laube, S (2005-07-01). "Pseudoxanthoma elasticum". Archives of Disease in Childhood. 90 (7): 754–756. doi:10.1136/adc.2004.062075. ISSN   0003-9888. PMC   1720489 . PMID   15970621.
12. "Mucopolysaccharidoses (MPS)". Johns Hopkins Medicine. 2021-08-08. Retrieved 2024-07-15.
13. Kaplan, Frederick S.; Le Merrer, Martine; Glaser, David L.; Pignolo, Robert J.; Goldsby, Robert E.; Kitterman, Joseph A.; Groppe, Jay; Shore, Eileen M. (2008). "Fibrodysplasia ossificans progressiva". Best Practice & Research Clinical Rheumatology. 22 (1): 191–205. doi:10.1016/j.berh.2007.11.007. ISSN   1521-6942. PMC   2424023 . PMID   18328989.
14. Stattin, E.-L.; Tegner, Y.; Domellöf, M.; Dahl, N. (2008). "Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature". Osteoarthritis and Cartilage. 16 (8): 890–896. doi:10.1016/j.joca.2007.11.009. ISSN   1063-4584. PMID   18226555.
15. Bennett, James; McMurray, Scott (November 1990). "Stickler Syndrome" . Journal of Pediatric Orthopaedics. 10 (6): 760–763. doi:10.1097/01241398-199011000-00010. PMID   2250061 . Retrieved 15 July 2024.
16. Warady, Bradley A.; Agarwal, Rajiv; Bangalore, Sripal; Chapman, Arlene; Levin, Adeera; Stenvinkel, Peter; Toto, Robert D.; Chertow, Glenn M. (2020). "Alport Syndrome Classification and Management". Kidney Medicine. 2 (5): 639–649. doi:10.1016/j.xkme.2020.05.014. ISSN   2590-0595. PMC   7568086 . PMID   33094278.
17. Tunçbilek, Ergül; Alanay, Yasemin (2006). "Congenital contractural arachnodactyly (Beals syndrome)". Orphanet Journal of Rare Diseases. 1 (1): 20. doi: 10.1186/1750-1172-1-20 . ISSN   1750-1172. PMC   1524931 . PMID   16740166.
18. Bardhan, Ajoy; Bruckner-Tuderman, Leena; Chapple, Iain L. C.; Fine, Jo-David; Harper, Natasha; Has, Cristina; Magin, Thomas M.; Marinkovich, M. Peter; Marshall, John F.; McGrath, John A.; Mellerio, Jemima E.; Polson, Rex; Heagerty, Adrian H. (2020-09-24). "Epidermolysis bullosa". Nature Reviews Disease Primers. 6 (1): 78. doi:10.1038/s41572-020-0210-0. ISSN   2056-676X. PMID   32973163.
19. Gouda, Pishoy; Kay, Robert; Habib, Marina; Aziz, Amir; Aziza, Eitan; Welsh, Robert (2022). "Clinical features and complications of Loeys-Dietz syndrome: A systematic review". International Journal of Cardiology. 362: 158–167. doi: 10.1016/j.ijcard.2022.05.065 . PMID   35662564.
20. Atwell, Karina; Michael, William; Dubey, Jared; James, Sarah; Martonffy, Andrea; Anderson, Scott; Rudin, Nathan; Schrager, Sarina (2021). "Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care". The Journal of the American Board of Family Medicine. 34 (4): 838–848. doi: 10.3122/jabfm.2021.04.200374 . ISSN   1557-2625. PMID   34312277.
21. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). "Guidelines for the management of rheumatoid arthritis: 2002 Update". Arthritis & Rheumatism. 46 (2): 328–346. doi:10.1002/art.10148. ISSN   0004-3591. PMID   11840435.
22. COJOCARU, Manole; COJOCARU, Inimioara Mihaela; SILOSI, Isabela; VRABIE, Camelia Doina (2024-03-14). "Manifestations of Systemic Lupus Erythematosus". Mædica. 6 (4): 330–336. PMC   3391953 . PMID   22879850.
23. Fett, Nicole (2013). "Scleroderma: Nomenclature, etiology, pathogenesis, prognosis, and treatments: Facts and controversies". Clinics in Dermatology. 31 (4): 432–437. doi:10.1016/j.clindermatol.2013.01.010. ISSN   0738-081X. PMID   23806160.
24. Mammen, Andrew L. (2010). "Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis". Annals of the New York Academy of Sciences. 1184 (1): 134–153. doi:10.1111/j.1749-6632.2009.05119.x. ISSN   0077-8923. PMID   20146695.
25. Roccatello, D; Emmi, L, eds. (2024). Connective Tissue Disease: A Comprehensive Guide - Volume 2. Springer Nature. ISBN   978-3-031-60855-1.
26. Cleveland Clinic medical professional (2024-05-01). "Vasculitis: Symptoms, Types & Treatment". Cleveland Clinic. Retrieved 2024-07-15.
27. Brito-Zerón, Pilar; Baldini, Chiara; Bootsma, Hendrika; Bowman, Simon J.; Jonsson, Roland; Mariette, Xavier; Sivils, Kathy; Theander, Elke; Tzioufas, Athanasios; Ramos-Casals, Manuel (2016-07-07). "Sjögren syndrome". Nature Reviews Disease Primers. 2 (1): 16047. doi:10.1038/nrdp.2016.47. hdl: 11568/809074 . ISSN   2056-676X. PMID   27383445.
28. Rullan, Eugenia; Sigal, Leonard H. (2001). "Rheumatic fever". Current Rheumatology Reports. 3 (5): 445–452. doi:10.1007/s11926-996-0016-4. ISSN   1523-3774. PMID   11564377.
29. Cleveland Clinic medical professional (2022-07-05). "Amyloidosis: What It Is, Symptoms, Types & Treatment". Cleveland Clinic. Retrieved 2024-07-16.
30. Sinusas, Keith (2012-01-01). "Osteoarthritis: Diagnosis and Treatment". American Family Physician. 85 (1): 49–56. PMID   22230308 . Retrieved 2024-07-16.
31. Joly, Bérangère S.; Coppo, Paul; Veyradier, Agnès (2017-05-25). "Thrombotic thrombocytopenic purpura". Blood. 129 (21): 2836–2846. doi:10.1182/blood-2016-10-709857. ISSN   0006-4971. PMID   28416507.
32. GERGELY, P (2004). "Relapsing polychondritis". Best Practice & Research Clinical Rheumatology. 18 (5): 723–738. doi:10.1016/j.berh.2004.05.012. ISSN   1521-6942. PMID   15454129.
33. Tani, Chiara; Carli, Linda; Vagnani, Sabrina; Talarico, Rosaria; Baldini, Chiara; Mosca, Marta; Bombardieri, Stefano (2014). "The diagnosis and classification of mixed connective tissue disease". Journal of Autoimmunity. 48–49: 46–49. doi:10.1016/j.jaut.2014.01.008. ISSN   0896-8411. PMID   24461387.
34. Mosca, Marta; Tani, Chiara; Vagnani, Sabrina; Carli, Linda; Bombardieri, Stefano (2014). "The diagnosis and classification of undifferentiated connective tissue diseases". Journal of Autoimmunity. 48–49: 50–52. doi:10.1016/j.jaut.2014.01.019. ISSN   0896-8411. PMID   24518855.
35. Ocampo D, Vanessa; Gladman, Dafna (2019-09-20). "Psoriatic arthritis". F1000Research. 8: 1665. doi: 10.12688/f1000research.19144.1 . ISSN   2046-1402. PMC   6758836 . PMID   31583079.
36. Stone, JH; Khosroshahi, A; Deshpande, V; Chan, JK; Heathcote, JG; Aalberse, R; Azumi, A; Bloch, DB; Brugge, WR; Carruthers, MN; Cheuk, W; Cornell, L; Castillo, CF; Ferry, JA; Forcione, D; Klöppel, G; Hamilos, DL; Kamisawa, T; Kasashima, S; Kawa, S; Kawano, M; Masaki, Y; Notohara, K; Okazaki, K; Ryu, JK; Saeki, T; Sahani, D; Sato, Y; Smyrk, T; Stone, JR; Takahira, M; Umehara, H; Webster, G; Yamamoto, M; Yi, E; Yoshino, T; Zamboni, G; Zen, Y; Chari, S (October 2012). "Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations". Arthritis and Rheumatism. 64 (10): 3061–7. doi:10.1002/art.34593. PMC   5963880 . PMID   22736240.

Further reading

• Spagnolo, Paolo; Cordier, Jean-François; Cottin, Vincent (2016-02-25). "Connective tissue diseases, multimorbidity and the ageing lung". European Respiratory Journal. 47 (5): 1535–1558. doi:10.1183/13993003.00829-2015. ISSN   0903-1936. PMID   26917611.
• Baildam, Eileen (2014). "Rare connective tissue diseases in childhood". Paediatrics and Child Health. 24 (2): 51–57. doi:10.1016/j.paed.2013.12.005.

External links

• "Connective Tissue Disorders". National Library of Medicine. 2017-09-15.
• Dunkin, Mary Anne (2023-10-10). "Connective Tissue Disease: Types, Symptoms, Causes". WebMD.
• "Connective tissue diseases". DermNet®. 2023-10-26.